CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $13.3B, above the global median of $1.18B
- PositionCurrent ratio is 0.95×, lower than 95% of its Diagnostics & Research peers (median 3.24×)
- Interpretations6 currently firing — 6
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
13.30BUSDvs all stocks (USD)
Trailing P/E
265.12xvs Diagnostics & Research peers
Revenue (TTM)
8.29BUSDvs all stocks (USD)
Profit Margin
0.33%vs Diagnostics & Research peers
Beta
1.20xvs all stocks
52-Week Change
5.44%vs all stocks
Market Capitalization
13.30BUSDvs all stocks (USD)
Enterprise Value
15.89BUSDvs all stocks (USD)
Trailing P/E
265.12xvs Diagnostics & Research peers
Forward P/E
14.61xvs Diagnostics & Research peers
PEG Ratio
-4.47xvs Diagnostics & Research peers
Price to Sales (TTM)
1.60xvs Diagnostics & Research peers
Price to Book (MRQ)
1.42xvs Diagnostics & Research peers
Enterprise to Revenue
1.92xvs Diagnostics & Research peers
Enterprise to EBITDA
30.36xvs Diagnostics & Research peers
Gross Margin
23.23%vs Diagnostics & Research peers
Profit Margin
0.33%vs Diagnostics & Research peers
Operating Margin
9.41%vs Diagnostics & Research peers
Return on Assets (TTM)
0.97%vs Diagnostics & Research peers
Return on Equity (TTM)
0.29%vs Diagnostics & Research peers
Revenue (TTM)
8.29BUSDvs all stocks (USD)
Revenue per Share (TTM)
107.96USDUpdated Sep 27, 2026Quarterly Revenue Growth
1.20%vs Diagnostics & Research peers
Gross Profit (TTM)
1.98BUSDvs all stocks (USD)
EBITDA (TTM)
1.23BUSDvs all stocks (USD)
Net Income (TTM)
27.04MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-64.30%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
1.11BUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
622.65MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 27, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Diagnostics & Research peers
Revenue
8.25BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
6.08BUSDFY2025 · Dec 31, 2025Gross Profit
2.18BUSDFY2025 · Dec 31, 2025Operating Income
1.01BUSDvs all stocks (USD)
Pre-tax Income
252.47MUSDFY2025 · Dec 31, 2025Income Tax Expense
23.13MUSDFY2025 · Dec 31, 2025Net Income
229.34MUSDFY2025 · Dec 31, 2025EBIT
440.57MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.39BUSDFY2025 · Dec 31, 2025Selling, General & Administrative
780.14MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
7.11MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
188.11MUSDFY2025 · Dec 31, 2025EPS (Basic)
2.73USDFY2025 · Dec 31, 2025EPS (Diluted)
2.71USDFY2025 · Dec 31, 2025Basic Shares Outstanding
78.42MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
78.42MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
229.34MUSDFY2025 · Dec 31, 2025Operating Cash Flow
540.78MUSDFY2025 · Dec 31, 2025Free Cash Flow
366.57MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
647.29MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
229.34MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
383.00MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-128.92MUSDFY2025 · Dec 31, 2025Stock-based Compensation
102.04MUSDFY2025 · Dec 31, 2025Other Non-cash Items
53.43MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-169.32MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
71.22MUSDFY2025 · Dec 31, 2025Capital Expenditures
-174.21MUSDFY2025 · Dec 31, 2025Net Acquisitions
-2.54MUSDFY2025 · Dec 31, 2025Purchase of Investments
-19.87MUSDFY2025 · Dec 31, 2025Sale of Investments
9.09MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-187.53MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
50.00MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-79.76MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-750.00MUSDFY2025 · Dec 31, 2025Other Financing Charges
-1.22MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-780.98MUSDFY2025 · Dec 31, 2025Shares Outstanding
77.15MSharesUpdated Sep 27, 2026Float Shares
77.10MSharesUpdated Sep 27, 2026Shares Short
2.63MSharesUpdated Sep 27, 2026Short Ratio
3.68daysvs all stocks
Short % of Shares Outstanding
3.85%vs all stocks
% Held by Insiders
0.44%vs all stocks
% Held by Institutions
108.34%vs all stocks
Total Cash (MRQ)
928.39MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
12.03USDUpdated Sep 27, 2026Total Debt (MRQ)
3.53BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.3760xvs Diagnostics & Research peers
Current Ratio (MRQ)
0.9530xvs Diagnostics & Research peers
Book Value per Share (MRQ)
121.55USDUpdated Sep 27, 2026Total Assets
16.27BUSDvs all stocks (USD)
Total Current Assets
3.50BUSDFY2025 · Dec 31, 2025Total Liabilities
7.08BUSDFY2025 · Dec 31, 2025Total Non-current Assets
12.77BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
3.88BUSDFY2025 · Dec 31, 2025Total Current Liabilities
3.20BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
647.29MUSDFY2025 · Dec 31, 2025Other Short-term Investments
0.00USDFY2025 · Dec 31, 2025Accounts Receivable
1.47BUSDFY2025 · Dec 31, 2025Accounts Payable
780.85MUSDFY2025 · Dec 31, 2025Short-term Debt
566.04MUSDFY2025 · Dec 31, 2025Deferred Revenue
1.55BUSDFY2025 · Dec 31, 2025Other Current Liabilities
39.51MUSDFY2025 · Dec 31, 2025Long-term Debt
2.99BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
72.81MUSDFY2025 · Dec 31, 2025Common Stock (Book)
6.30MUSDFY2025 · Dec 31, 2025Retained Earnings
2.12BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
9.19BUSDvs all stocks (USD)
52-Week Low
66.57USDUpdated Sep 27, 202652-Week High
203.91USDUpdated Sep 27, 202652-Week Change
5.44%vs all stocks
Beta
1.20xvs all stocks
50-Day MA
167.33USDUpdated Sep 27, 2026200-Day MA
146.88USDUpdated Sep 27, 2026Avg 10-Day Volume
1.10MSharesUpdated Sep 27, 2026Avg 30-Day Volume
805.79KSharesUpdated Sep 27, 2026Diluted EPS (TTM)
0.6500USDUpdated Sep 27, 2026Other Income / Expense
-569.61MUSDFY2025 · Dec 31, 20256 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Diagnostic
Goodwill-Heavy Asset Growth With a Recent Reversal
Assets grew over the long run on acquired goodwill, but have shrunk in each of four years.
Reads
Diagnostic
Debt Falling While Share Count Rises
Debt has fallen for four years while the share count rose over eight.
Reads
Multi-Year Cash Increase With FCF And Debt Decrease
Cash up four years running while long-term debt fell for three.
Reads
How does this company use capital?
Diagnostic
Depreciation-Heavy Reported Profit
It reports a profit, and much of the gap to cash is depreciation rather than earnings.
Reads
Cash-Backed Earnings Configuration
More cash comes in than it reports as profit, little goes back out on equipment, and much of the gap is depreciation.
Reads
How is this stock valued?
Drawdown With FCF And Cash Backing
Well below its peak, with three years of positive free cash flow behind it.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 0.95×, lower than 95% of its Diagnostics & Research peers (median 3.24×)Significant
Current ratio: 0.95Industry median: 3.24Industry P5: 1.26Peers compared: 29.00
Price-to-book is 1.42×, lower than 95% of its Diagnostics & Research peers (median 3.02×)Notable
Price-to-book: 1.42Industry median: 3.02Industry P5: 1.55Peers compared: 29.00
Structural Tensions
Prioritizing buybacks over growth reinvestmentNotable
Buyback Intensity: 0.06Revenue Growth YoY: 0.01
Financial Health
Altman Z-Score 1.93: grey zoneSignificant
Altman Z-Score: 1.93
High earnings qualityNotable
Earnings Quality Score: 0.86
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $13.3B, above the global median of $1.18BNotable
Market cap (USD): 13,295,984,836Global Median: 1,180,223,658.953
Revenue is $8.29B, above the global median of $548.88MNotable
Revenue (USD): 8,294,416,896Global Median: 548,883,780.48
Levered free cash flow is $622.65M, above the global median of $18.73MNotable
Levered free cash flow (USD): 622,646,656Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Amkor Technology Inc.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Polycab India Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Mueller Industries Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Skyworks Solutions Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Vicor Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
SomniGroup International Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRisk
Anhui Conch Cement Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Taiwan Union Technology Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Trimble Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Jiangsu Eastern Shenghong Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Dxc Technology Co.
3 interpretationsDrawdown With FCF And Cash BackingCash-Backed Earnings ConfigurationDepreciation-Heavy Reported Profit
Herc Holdings Inc.
2 interpretationsDrawdown With FCF And Cash BackingCash-Backed Earnings Configuration
Molina Healthcare Inc.
1 interpretationDepreciation-Heavy Reported Profit